Literature DB >> 8254109

Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease.

M Emre1, S Heckers, D C Mash, C Geula, M M Mesulam.   

Abstract

The cholinergic innervation of the human amygdaloid complex was studied immunohistochemically with a choline acetyltransferase (ChAT) antibody in eight brains: five control and three with Alzheimer's disease (AD). All amygdaloid nuclei displayed ChAT-immunopositive axons and varicosities. The density of these axons reached levels that were higher than in any other part of the forebrain except for the striatum. The highest level of ChAT-immunopositive profiles was seen in the basolateral nucleus and the second highest in the lateral part of the central nucleus. The basomedial, accessory basal, and cortical nuclei, the amygdalohippocampal and cortico-amygdaloid transition areas, as well as the anterior amygdaloid area, showed a moderate density of ChAT-positive varicosities and fibers. The lateral nucleus displayed a relatively low density of cholinergic innervation, and there were only rare ChAT-positive fibers in the medial nucleus. Although the level of cholinergic innervation in the lateral nucleus was relatively lower than in many of the other amygdaloid nuclei, it was approximately equivalent to that of entorhinal cortex, a region that receives one of the heaviest cholinergic inputs in the cerebral cortex. The distribution of the cholinergic fibers as studied by ChAT immunohistochemistry was nearly identical to that observed with AChE histochemistry. Quantitative densitometry in control specimens showed that there was no decline of amygdaloid cholinergic input when middle-aged subjects were compared with senescent subjects. In AD there was a severe and regionally selective depletion of this innervation in the amygdaloid complex. The cortical, accessory basal, and lateral nuclei displayed the most severe loss of ChAT-positive profiles, whereas the basolateral, and especially the central, nuclei displayed relatively little change. There was no consistent relationship between the loss of cholinergic fibers and the density of amyloid plaques and neurofibrillary tangles in amygdaloid nuclei.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8254109     DOI: 10.1002/cne.903360110

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  17 in total

1.  Nerve growth factor (NGF) augments cortical and hippocampal cholinergic functioning after p75NGF receptor-mediated deafferentation but impairs inhibitory avoidance and induces fear-related behaviors.

Authors:  J Winkler; G A Ramirez; L J Thal; J J Waite
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

2.  Neutral and emotional episodic memory: global impairment after lorazepam or scopolamine.

Authors:  Sunjeev K Kamboj; H Valerie Curran
Journal:  Psychopharmacology (Berl)       Date:  2006-09-19       Impact factor: 4.530

3.  Functional neuroanatomy of the basolateral amygdala: Neurons, neurotransmitters, and circuits.

Authors:  Alexander J McDonald
Journal:  Handb Behav Neurosci       Date:  2020-03-31

Review 4.  Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease.

Authors:  M-Marsel Mesulam
Journal:  J Comp Neurol       Date:  2013-12-15       Impact factor: 3.215

5.  Cholinergic innervation of pyramidal cells and parvalbumin-immunoreactive interneurons in the rat basolateral amygdala.

Authors:  Jay F Muller; Franco Mascagni; Alexander J McDonald
Journal:  J Comp Neurol       Date:  2011-03-01       Impact factor: 3.215

6.  The Basal Forebrain Regulates Global Resting-State fMRI Fluctuations.

Authors:  Janita Turchi; Catie Chang; Frank Q Ye; Brian E Russ; David K Yu; Carlos R Cortes; Ilya E Monosov; Jeff H Duyn; David A Leopold
Journal:  Neuron       Date:  2018-02-01       Impact factor: 17.173

7.  Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease.

Authors:  Nicolaas I Bohnen; Martijn L T M Müller; Vikas Kotagal; Robert A Koeppe; Michael A Kilbourn; Roger L Albin; Kirk A Frey
Journal:  Brain       Date:  2010-04-22       Impact factor: 13.501

8.  Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.

Authors:  Sylvia E Perez; Saleem Dar; Milos D Ikonomovic; Steven T DeKosky; Elliott J Mufson
Journal:  Neurobiol Dis       Date:  2007-06-27       Impact factor: 5.996

9.  Regional vesicular acetylcholine transporter distribution in human brain: A [18 F]fluoroethoxybenzovesamicol positron emission tomography study.

Authors:  Roger L Albin; Nicolaas I Bohnen; Martijn L T M Muller; William T Dauer; Martin Sarter; Kirk A Frey; Robert A Koeppe
Journal:  J Comp Neurol       Date:  2018-10-19       Impact factor: 3.215

10.  Volume Loss of the Nucleus Basalis of Meynert is Associated with Atrophy of Innervated Regions in Mild Cognitive Impairment.

Authors:  Jose L Cantero; Laszlo Zaborszky; Mercedes Atienza
Journal:  Cereb Cortex       Date:  2017-08-01       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.